MeiraGTx Holdings PLC (MGTX)
4.14
-0.07
(-1.66%)
USD |
NASDAQ |
Jun 26, 13:44
MeiraGTx Holdings Price to Book Value: 2.187 for June 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 25, 2024 | 2.224 |
| June 24, 2024 | 2.250 |
| June 21, 2024 | 2.324 |
| June 20, 2024 | 2.277 |
| June 18, 2024 | 2.256 |
| June 17, 2024 | 2.319 |
| June 14, 2024 | 2.372 |
| June 13, 2024 | 2.435 |
| June 12, 2024 | 2.478 |
| June 11, 2024 | 2.541 |
| June 10, 2024 | 2.536 |
| June 07, 2024 | 2.520 |
| June 06, 2024 | 2.573 |
| June 05, 2024 | 2.631 |
| June 04, 2024 | 2.599 |
| June 03, 2024 | 2.610 |
| May 31, 2024 | 2.588 |
| May 30, 2024 | 2.636 |
| May 29, 2024 | 2.641 |
| May 28, 2024 | 2.715 |
| May 24, 2024 | 2.792 |
| May 23, 2024 | 2.715 |
| May 22, 2024 | 2.990 |
| May 21, 2024 | 2.905 |
| May 20, 2024 | 2.926 |
| Date | Value |
|---|---|
| May 17, 2024 | 3.016 |
| May 16, 2024 | 3.000 |
| May 15, 2024 | 2.921 |
| May 14, 2024 | 2.763 |
| May 13, 2024 | 2.715 |
| May 10, 2024 | 2.678 |
| May 09, 2024 | 2.694 |
| May 08, 2024 | 2.715 |
| May 07, 2024 | 2.842 |
| May 06, 2024 | 2.676 |
| May 03, 2024 | 2.641 |
| May 02, 2024 | 2.636 |
| May 01, 2024 | 2.636 |
| April 30, 2024 | 2.578 |
| April 29, 2024 | 2.594 |
| April 26, 2024 | 2.536 |
| April 25, 2024 | 2.488 |
| April 24, 2024 | 2.567 |
| April 23, 2024 | 2.604 |
| April 22, 2024 | 2.652 |
| April 19, 2024 | 2.689 |
| April 18, 2024 | 2.647 |
| April 17, 2024 | 2.773 |
| April 16, 2024 | 2.858 |
| April 15, 2024 | 2.890 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.796
Minimum
Mar 16 2020
7.723
Maximum
Jul 09 2019
3.275
Average
2.958
Median
Oct 03 2023
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals Inc | 4.356 |
| CEL-SCI Corp | 4.468 |
| AIM ImmunoTech Inc | 4.958 |
| IGC Pharma Inc | 3.534 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 21.94 |
| Price | 4.14 |
| Earnings Yield | -28.26% |
| Market Cap | 266.23M |